Serum-free medium for mesenchymal stem cells (MSCs) and preparation method of serum-free medium
A serum-free medium and stromal cell technology, applied in the field of serum-free medium for mesenchymal stem cells and their preparation, can solve the scientific research or clinical needs of mesenchymal stem cells, limit the application of serum-free medium, and slow the proliferation rate and other problems, to achieve the effect of helping cells maintain activity, avoid blood-borne contamination, and maintain a good growth state.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] A serum-free medium for umbilical cord mesenchymal stem cells, including basal medium DMEM / F12, based on the final concentration of the medium, also includes the following components: recombinant human insulin 7.0mg / L, cholesterol 3.0mg / L, recombinant fibronectin 24.7ng / L, sodium linoleate 16.5μg / L, recombinant human transferrin 11.5mg / L, perilla seed protein 6.0mg / L, stilbene glycoside 9.0μg / L, white Veratrol 7.3μg / L, Ginkgo biloba extract 8.5μg / L.
[0028] The preparation method of the serum-free medium for umbilical cord mesenchymal stem cells comprises the following steps: adding recombinant human insulin, cholesterol, recombinant fibronectin, sodium linoleate, recombinant human transferrin, and perilla seed protein to the basal medium , stilbene glycosides, resveratrol, and ginkgo biloba extract, mixed evenly, filtered with a filter membrane with a pore size of 0.22 μm, and sterilized to obtain a serum-free medium for umbilical cord mesenchymal stem cells.
Embodiment 2
[0030] A serum-free medium for umbilical cord mesenchymal stem cells, including basal medium DMEM / F12, based on the final concentration of the medium, also includes the following components: recombinant human insulin 6.5mg / L, cholesterol 1.5mg / L, recombinant fibronectin 22.3μg / L, sodium linoleate 15.4μg / L, recombinant human transferrin 8.3mg / L, perilla seed protein 5.0mg / L, stilbene glycoside 8.5μg / L, white Veratrol 5.8μg / L, Ginkgo biloba extract 7.3μg / L.
[0031] The preparation method of the above serum-free medium for umbilical cord mesenchymal stem cells is the same as in Example 1.
Embodiment 3
[0033] A serum-free medium for umbilical cord mesenchymal stem cells, including basal medium DMEM / F12, based on the final concentration of the medium, also includes the following components: recombinant human insulin 9.0mg / L, cholesterol 4.0mg / L, recombinant fibronectin 25.0ng / L, sodium linoleate 17.2μg / L, recombinant human transferrin 12.4mg / L, perilla seed protein 8.0mg / L, stilbene glycoside 9.5μg / L, white Veratrol 8.4μg / L, Ginkgo biloba extract 9.0μg / L.
[0034] The preparation method of the above serum-free medium for umbilical cord mesenchymal stem cells is the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com